Financials

  • Market Capitalization 2.32 B
  • Employee 357
  • Founded 2009
  • CEO N/A
  • Website www.nurixtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDJ8M78
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.54
ratio cours/chiffre d'affaires
17.45

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1847
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
4.36 USD+10.38%+4.31%+36.25%-20.73%2.33 B USD
1850
ADMA
ADMA Biologics Inc - Common Stock
10.36 USD+0.29%+7.58%+11.04%-28.85%2.32 B USD
1884
IMNM
Immunome, Inc. - Common Stock
19.55 USD+1.24%-5.96%-20.20%+40.45%2.22 B USD
1887
AUPH
Aurinia Pharmaceuticals Inc - Common Shares
16.65 USD+2.65%+5.65%+3.16%+39.56%2.22 B USD

Nouvelles